Table 5

Cumulative Incidence of Clinical Outcomes by Quartiles of Total Stent Length per Patient During 3-Year Follow-Up

Quartile 1 (8–18 mm)Quartile 2 (18–24 mm)Quartile 3 (24–36 mm)Quartile 4 (≥36 mm)p Value
n = 782 (14.0%)n = 1,706 (32.0%)n = 1,329 (25.0%)n = 1,586 (29.0%)
MACE
 0–3 yrs60 (9.17%)158 (11.05%)167 (14.36%)260 (19.58%)<0.0001
 0–1 yr41 (5.27%)89 (5.27%)128 (9.72%)201 (12.79%)<0.0001
 1–3 yrs19 (4.11%)69 (6.10%)39 (5.14%)59 (7.79%)0.0449
Key safety endpoint
 0–3 yrs41 (6.20%)95 (6.69%)114 (9.81%)173 (12.66%)<0.0001
 0–1 yr30 (3.86%)51 (3.01%)87 (6.59%)141 (8.94%)<0.0001
 1–3 yrs11 (2.43%)44 (3.79%)27 (3.44%)32 (4.09%)0.4991
All-cause death or MI
 0–3 yrs39 (5.93%)94 (6.63%)112 (9.71%)172 (12.61%)<0.0001
 0–1 yr28 (3.60%)50 (2.95%)84 (6.36%)140 (8.88%)<0.0001
 1–3 yrs11 (2.42%)44 (3.78%)28 (3.57%)32 (4.10%)0.5157
All-cause death
 0–3 yrs24 (3.83%)57 (4.19%)65 (6.08%)78 (6.40%)0.0062
 0–1 yr15 (1.93%)22 (1.31%)38 (2.89%)49 (3.12%)0.0021
 1–3 yrs9 (1.93%)35 (2.92%)27 (3.28%)29 (3.38%)0.4988
Cardiac death
 0–3 yrs12 (1.97%)26 (2.79%)37 (4.17%)46 (4.61%)0.0146
 0–1 yr8 (1.08%)16 (1.37%)26 (2.34%)33 (2.55%)0.0390
 1–3 yrs4 (0.89%)10 (1.44%)11 (1.87%)13 (2.12%)0.4480
MI
 0–3 yrs15 (2.12%)43 (2.85%)60 (4.80%)108 (7.43%)<0.0001
 0–1 yr13 (1.67%)32 (1.89%)55 (4.17%)99 (6.30%)<0.0001
 1–3 yrs2 (0.46%)11 (0.98%)5 (0.65%)9 (1.21%)0.5001
Definite/probable ST
 0–3 yrs5 (0.65%)18 (1.18%)15 (1.22%)15 (1.09%)0.7397
 0–1 yr5 (0.65%)12 (0.71%)14 (1.08%)12 (0.77%)0.6560
 1–3 yrs0 (0.00%)6 (0.48%)1 (0.14%)3 (0.33%)0.2531
TLR
 0–3 yrs27 (4.07%)80 (5.51%)68 (5.95%)113 (9.13%)<0.0001
 0–1 yr19 (2.48%)50 (2.97%)53 (4.11%)79 (5.14%)0.0023
 1–3 yrs8 (1.63%)30 (2.62%)15 (1.93%)34 (4.23%)0.0131

Values are n (Kaplan-Meier %). The key safety endpoint was defined as a composite of all-cause death, myocardial infarction, or definite/probable ST.

Abbreviations as in Tables 1 and 3.